- Page 2 and 3:
ForewordMedication safety and provi
- Page 4 and 5:
Chapter 6 summarizes the specific r
- Page 6 and 7:
Chapter 6Conclusions and Recommenda
- Page 8 and 9:
CHAPTER ONETHE WORKING GROUPMEMBERS
- Page 10 and 11:
CHAPTER TWOTHE PROGRESS REPORT2.1 P
- Page 12 and 13:
CHAPTER THREEAREAS FOR IMPROVEMENT
- Page 14 and 15:
Existing In-patient Drug Administra
- Page 16 and 17:
Existing In-patient Drug Administra
- Page 18 and 19:
Existing In-patient Drug Administra
- Page 20 and 21:
Existing In-patient Drug Administra
- Page 22 and 23:
CHAPTER FOURRECOMMENDED PRACTICES A
- Page 24 and 25:
Drug Name4.11 There should be a hos
- Page 26 and 27:
Electronic prescribing (Medication
- Page 28 and 29:
4.46 When the use of CM is permitte
- Page 30 and 31:
cytotoxic and central intravenous a
- Page 32 and 33:
4.72 Special precautions should be
- Page 34 and 35:
4.84 To prevent mixing up medicatio
- Page 36 and 37:
The Principle of Three checks and F
- Page 38 and 39:
4.111 Three-way (red and blue) and
- Page 40 and 41:
or their discharge or death, should
- Page 42 and 43:
operational requirement but also it
- Page 44 and 45:
Quality Complaints on Pharmaceutica
- Page 46 and 47:
LEVELSHAHOCE / DTOOLS & MECHANISMDU
- Page 48 and 49:
Medication Incident Report<
- Page 50 and 51:
Continuing Education6.18 In order t
- Page 52 and 53:
APPENDICESAppendix 1Appendix 2Appen
- Page 54 and 55: Hospital Authority Hospital No. : I
- Page 56 and 57: Sensitivity:Prescription/ routewith
- Page 58 and 59: Appendix 3aLists of HA-wide Approve
- Page 60 and 61: DRUGTeniposideABBREVIATIONVM-26Thia
- Page 62 and 63: Appendix 3b“Do Not Use Abbreviati
- Page 64 and 65: Appendix 4Schedule for the Administ
- Page 66 and 67: Appendix 5Mechanism for the Managem
- Page 68 and 69: 4. As with all medications, there s
- Page 70 and 71: Appendix 6HA Guideline on Safe Mana
- Page 72 and 73: 2.1 Concentrated potassium chloride
- Page 74 and 75: Appendix 7Supply of Antidotes and D
- Page 76 and 77: 複 本 Antidotes and emeg drug lis
- Page 78 and 79: Appendix 8Guidelines for Supply of
- Page 80 and 81: substitution with other drugs in ac
- Page 82 and 83: Appendix 9Samples of the Line Label
- Page 84 and 85: Appendix 10Guidelines on the use of
- Page 86 and 87: Appendix 11Guidelines on Patient Se
- Page 88 and 89: Operational Guidelines7. The operat
- Page 90 and 91: COC(N) Paper 12/2004Approved by COC
- Page 92 and 93: 7.4 Evaluation Record and report th
- Page 94 and 95: DISPOSAL OF HOSPITAL PHARMACEUTICAL
- Page 96 and 97: Appendix 14Guidelines on the Handli
- Page 98 and 99: Appendix 15Medication Incident <str
- Page 100 and 101: Hospital Authority Medication Incid
- Page 102 and 103: QUALITY ASSURANCE IN DRUG THERAPYHO
- Page 106 and 107: PROCEUDRE FOR QUALITY COMPLAINTSONP
- Page 108: Part II Procurement Section, CPO1.